Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cellular Adaptation IV: Dysplasia and Metaplasia

Cellular Adaptation IV: Dysplasia and Metaplasia

DysplasiaDysplasia refers to abnormal changes in the size, shape, and organization of mature cells, characterized by pleomorphism, nuclear abnormalities, and increased mitotic activity. It commonly affects epithelial tissues, including the cervix, gastrointestinal tract, respiratory mucosa, and endometrium. Although it may occur alongside hyperplasia, dysplasia is not a true adaptive response but a preneoplastic change with potential to progress to cancer.When confined above the basement...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rare Duodenal Varix Coil Erosion Post TIPS Creation and Coil Embolization of Mesenteric-Systemic Shunt.

Digestive diseases and sciences·2017

Same author

Safety and efficacy of endoscopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia.

Gastrointestinal endoscopy·2010

Same author

Endoscopic spray cryotherapy for esophageal cancer: safety and efficacy.

Gastrointestinal endoscopy·2010

Same author

Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia.

Gastroenterology·2008

Same author

Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.

Gastrointestinal endoscopy·2007

Same author

Management of pancreas divisum.

Current treatment options in gastroenterology·2006

Search research articles

Related Experiment Video

Updated: Jul 3, 2026

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Published on: April 17, 2026

Intraductal papillary mucinous neoplasms.

J Steven Burdick¹

¹Baylor University Medical Center, 3600 Gaston Avenue, Dallas, TX 75246, USA. j.burdick@baylorhealth.edu

Gastrointestinal Endoscopy Clinics of North America

|August 5, 2008

Summary

This summary is machine-generated.

Intraductal papillary mucinous neoplasms (IPMNs) are pancreatic tumors with high mucus secretion. Surgical treatment for IPMN involves complex decisions balancing resection extent against cancer risks in the remaining pancreas.

More Related Videos

Intraductal Delivery to the Rabbit Mammary Gland

Intraductal Delivery to the Rabbit Mammary Gland

Published on: March 9, 2017

Intraductal Injection for Localized Drug Delivery to the Mouse Mammary Gland

Intraductal Injection for Localized Drug Delivery to the Mouse Mammary Gland

Published on: October 4, 2013

Related Experiment Videos

Last Updated: Jul 3, 2026

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Robotic Duodenum-preserving Total Pancreatic Head Resection for Intraductal Papillary Mucinous Neoplasms

Published on: April 17, 2026

Intraductal Delivery to the Rabbit Mammary Gland

Intraductal Delivery to the Rabbit Mammary Gland

Published on: March 9, 2017

Intraductal Injection for Localized Drug Delivery to the Mouse Mammary Gland

Intraductal Injection for Localized Drug Delivery to the Mouse Mammary Gland

Published on: October 4, 2013

Area of Science:

Gastroenterology
Surgical Oncology
Pancreatic Pathology

Background:

Intraductal papillary mucinous neoplasm (IPMN) is a pancreatic neoplasm characterized by mucin hypersecretion.
IPMNs present with a dilated main pancreatic duct, patulous ampullary orifice, and abundant mucus.
While often benign, IPMN can harbor foci of invasive pancreatic cancer.

Purpose of the Study:

To discuss the surgical management of IPMN.
To explore the controversies surrounding the extent of pancreatic resection for IPMN.
To evaluate the risks associated with total pancreatectomy versus conservative management.

Main Methods:

Review of current literature on IPMN diagnosis and treatment.
Analysis of surgical outcomes and long-term follow-up data for IPMN patients.
Discussion of risk stratification and decision-making in IPMN management.

Main Results:

Surgery is the only curative treatment for IPMN.
Controversies exist regarding optimal surgical margins and extent of resection.
Total pancreatectomy carries significant risks that must be weighed against the risk of malignancy in the residual pancreas.

Conclusions:

Treatment decisions for IPMN require careful consideration of individual patient factors.
Balancing the risks of major surgery against the natural history and malignant potential of IPMN is crucial.
Further research is needed to optimize surgical strategies and improve outcomes for IPMN patients.